M
Momenta Pharmaceuticals
Biotechnology company specializing in the characterization and process engineering of complex molecules
At a glance
- Founded
- 2001
- Headquarters
- Cambridge, United States
- Listing
- IPO 2004
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Momenta Pharmaceuticals.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later5 investors entered at this stage
- MPMVM Life Science Partners
- MVMithra Ventures
- CPCardinal Partners
Atlas Venture- MTMassachusetts Institute of Technology
Source: Dealroom Talent Intelligence.
Alumni founders
Former Momenta Pharmaceuticals employees who went on to found companies, sorted by Dealroom signal score.
VIVisterraEst. 2007
Ram SasisekharanUnited States
MBMitra BiotechEst. 2009
STSunflower TherapeuticsEst. 2018
Kathryn GoldenUnited States
AFAffinivaxEst. 2014
Steven BruggerUnited States
OVOvaScienceEst. 2011
Christoph WestphalUnited StatesGlobal footprint
team presence
across markets
Patents
58 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Momenta Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Momenta Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.